+499.5%
MRNA vs ALB
+60.9%
+438.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ALB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -4.4% | +2.2% | -0.8% |
| 7D | +5.5% | -8.1% | +13.5% | +8.4% |
| 30D | +158.7% | +6.3% | +152.5% | +153.6% |
| 3M | +182.1% | -23.6% | +205.7% | +203.4% |
| 6M | +151.8% | -24.6% | +176.4% | +167.6% |
| YTD | +393.6% | -10.3% | +403.8% | +398.5% |
| 1Y | +499.5% | +61.5% | +438.0% | +469.5% |
| All | +499.5% | +60.9% | +438.5% | +469.5% |
Cumulative growth
Daily Returns
Daily percentage return beside ALB.
Daily Out/Under-Performance
Portfolio return minus ALB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ALB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling